Cisplatin, Etoposide, and Irinotecan for Relapsed Small-Cell Lung Cancer

Benzer Materyaller

• Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
  Yazar:: Goto, K, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• E5501 - Phase II Study of Topotecan Sequenced with Etoposide/Cisplatin, and Irinotecan/Cisplatin Sequenced with Etoposide for Extensive Stage Small Cell Lung Cancer
  Yazar:: Owonikoko, Taofeek K., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer
  Yazar:: Xiao, Xiaoguang, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial
  Yazar:: Shi, Yuankai, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer
  Yazar:: Sekine, I, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)